News & HighlightsNews
Will SARS-CoV-2 escape future drugs by mutating? The answer may be a nuanced 鈥渘o.鈥�

Scientists hope to deploy antibodies in the quest to end COVID-19. A recent study moves them closer to accomplishing a key step: finding out if the virus may acquire resistance to antibody-based drugs or vaccines, and how to potent...

How toothless mock viruses could advance research on COVID-19
Scientists have engineered听four viruses resembling SARS-CoV-2 to enable faster and safer research on vaccines and treatments.
Brain study finds a molecular 鈥渙ff鈥� switch for nicotine craving
In findings that might lead to better smoking-cessation tools, scientists have shown that manipulating a specific brain receptor can alter a mouse鈥檚 nicotine sensitivity.
Unique mutation reveals a new role for well-known DNA-repair gene
The discovery of a rare mutation in BRCA2, commonly known as the breast cancer gene, has shed new light on how cells safeguard their genetic material.
 
3D imaging of blood vessels could shed new light on cardiovascular disease
The new imaging technique enables researchers to construct a comprehensive image of blockages and other vascular injuries.
Rockefeller scientists launch a broad range of studies into novel coronavirus
Over 130 scientists in 18 labs are conducting research to advance the development of new, urgently needed approaches for the prevention and treatment of COVID-19.
How skin cells embark on a swift yet elaborate death
Scientists have identified the mechanism that allows skin cells to sense changes in their environment, and very quickly respond to reinforce the skin's outermost layer. The findings provide insight into how errors in this process might lead to skin conditions like psoriasis.  
Rockefeller grants commercial license for the development of new HIV drugs
The novel compounds are based on so-called broadly neutralizing antibodies, molecules that make rare people's immune systems capable of fighting HIV. They could potentially yield new treatment and prevention approaches benefitting people around the world, including in developing countries.
Neuron-like activity detected in an unforeseen place
Scientists have identified a particular type of skin cell that looks and behaves similar to a nerve cell, prompting new questions about the body's biggest organ.
Small containers inside cells might offer new targets for cancer treatment
For reasons that have long been unclear, cells stop dividing when the pH rises inside tiny cellular compartments called lysosomes. Now scientists have found an explanation for this phenomenon, with potential implications for drug development.
View
View